KalVista Pharmaceuticals (KALV) Institutional Ownership $13.16 +0.17 (+1.31%) Closing price 04:00 PM EasternExtended Trading$13.18 +0.02 (+0.11%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for KalVista Pharmaceuticals (NASDAQ:KALV)Number ofInstitutional Buyers(last 12 months)88TotalInstitutional Inflows(last 12 months)$163.02MNumber ofInstitutional Sellers(last 12 months)38TotalInstitutional Outflows(last 12 months)$43.99M Get KALV Insider Trade Alerts Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data KALV Institutional Buying and Selling by Quarter KalVista Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 8,059$91K0.0%+816.8%0.016% 8/15/2025 Vestal Point Capital LP4,675,000$52.85M2.8%-1.6%9.359% 8/15/2025 Rafferty Asset Management LLC46,901$530K0.0%+78.5%0.094% 8/15/2025 Rosalind Advisors Inc.157,725$1.78M0.8%-48.1%0.316% 8/15/2025 Octagon Capital Advisors LP1,273,333$14.40M3.2%-7.1%2.549% 8/15/2025 BNP Paribas Financial Markets4,041$46K0.0%+47.0%0.008% 8/15/2025 Brevan Howard Capital Management LP13,333$151K0.0%N/A0.027% 8/15/2025 Bank of America Corp DE366,966$4.15M0.0%+19.0%0.735% 8/15/2025 Ameriprise Financial Inc.945,125$10.69M0.0%+2,258.6%1.892% 8/14/2025 Raymond James Financial Inc.101,035$1.14M0.0%N/A0.202% Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.22,964$260K0.0%-5.6%0.046% 8/14/2025 The Manufacturers Life Insurance Company 14,626$165K0.0%+5.9%0.029% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 79,460$898K0.0%-53.2%0.159% 8/14/2025 Stempoint Capital LP386,790$4.37M1.4%-20.6%0.774% 8/14/2025 Qube Research & Technologies Ltd97,248$1.10M0.0%N/A0.195% 8/13/2025 Marshall Wace LLP119,622$1.35M0.0%+47.7%0.239% 8/13/2025 Stonepine Capital Management LLC100,000$1.13M1.1%+364.0%0.200% 8/13/2025 Saturn V Capital Management LP62,793$710K0.3%-75.4%0.126% 8/13/2025 Invesco Ltd.50,761$574K0.0%+27.5%0.102% 8/13/2025 OMERS ADMINISTRATION Corp33,900$383K0.0%N/A0.068% 8/13/2025 Panagora Asset Management Inc.292,593$3.31M0.0%+307.0%0.586% 8/13/2025 Schroder Investment Management Group554,958$6.27M0.0%-36.1%1.111% 8/13/2025 Virtus Investment Advisers LLC7,184$81K0.0%N/A0.014% 8/13/2025 F m Investments LLC182,262$2.06M0.1%+263.8%0.365% 8/13/2025 Quadrature Capital Ltd19,973$226K0.0%N/A0.040% 8/12/2025 Rhumbline Advisers54,376$615K0.0%+2.8%0.109% 8/12/2025 Legal & General Group Plc4,202$48K0.0%-50.8%0.008% 8/12/2025 JPMorgan Chase & Co.23,218$262K0.0%-94.2%0.046% 8/8/2025 Creative Planning33,380$377K0.0%+20.0%0.067% 8/8/2025 Police & Firemen s Retirement System of New Jersey9,756$110K0.0%+26.8%0.020% 8/8/2025 Geode Capital Management LLC941,212$10.64M0.0%+2.8%1.884% 8/8/2025 Nan Fung Trinity HK Ltd.154,522$1.75M0.2%N/A0.309% 8/7/2025 Profund Advisors LLC10,020$113K0.0%N/A0.020% 8/4/2025 Emerald Mutual Fund Advisers Trust768,972$8.69M0.5%+26.4%1.539% 8/4/2025 Emerald Advisers LLC1,038,049$11.74M0.4%+15.6%2.078% 8/4/2025 Whalen Wealth Management Inc.10,938$124K0.1%N/A0.022% 7/25/2025 CWM LLC3,627$41K0.0%-20.9%0.007% 6/27/2025 Goldman Sachs Group Inc.339,936$3.92M0.0%+3.7%0.684% 6/18/2025 Voya Investment Management LLC10,239$118K0.0%-17.4%0.021% 5/29/2025 Rhumbline Advisers52,918$611K0.0%+3.4%0.106% “Sell Nvidia before earnings” (Ad)Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.See Eric’s full analysis and get all 7 free trade ideas here5/16/2025 Woodline Partners LP1,617,469$18.67M0.1%+25.5%3.253% 5/16/2025 Goldman Sachs Group Inc.339,936$3.92M0.0%+3.7%0.684% 5/16/2025 Parkman Healthcare Partners LLC753,752$8.70M1.0%N/A1.516% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,325$281K0.0%+13.7%0.049% 5/16/2025 AQR Capital Management LLC55,975$646K0.0%N/A0.113% 5/16/2025 Allostery Investments LP458,302$5.29M7.6%-4.3%0.922% 5/16/2025 Adage Capital Partners GP L.L.C.276,000$3.19M0.0%-8.0%0.555% 5/15/2025 Vestal Point Capital LP4,751,292$54.83M3.9%-0.4%9.557% 5/15/2025 PDT Partners LLC23,654$273K0.0%-32.8%0.048% 5/15/2025 Quarry LP8,400$97K0.0%N/A0.017% 5/15/2025 DAFNA Capital Management LLC752,359$8.68M2.5%-7.3%1.513% 5/14/2025 Ieq Capital LLC10,915$126K0.0%N/A0.022% 5/14/2025 Rafferty Asset Management LLC26,269$303K0.0%-51.8%0.053% 5/14/2025 Corebridge Financial Inc.19,094$220K0.0%+12.7%0.038% 5/14/2025 MetLife Investment Management LLC21,688$250K0.0%+13.2%0.044% 5/14/2025 Stonepine Capital Management LLC21,550$249K0.2%N/A0.043% 5/14/2025 Walleye Capital LLC249,161$2.88M0.0%-6.9%0.501% 5/14/2025 Wellington Management Group LLP126,268$1.46M0.0%+2.8%0.254% 5/13/2025 Russell Investments Group Ltd.53,028$612K0.0%-60.3%0.107% 5/12/2025 Nuveen LLC37,321$431K0.0%N/A0.075% 5/12/2025 Invesco Ltd.39,804$459K0.0%+154.5%0.080% 5/9/2025 Deutsche Bank AG32,126$371K0.0%-10.4%0.065% 5/9/2025 Charles Schwab Investment Management Inc.113,124$1.31M0.0%+12.7%0.228% 5/9/2025 Vanguard Group Inc.2,298,598$26.53M0.0%+1.9%4.623% 5/9/2025 Earned Wealth Advisors LLC3,845$44K0.0%N/A0.008% 5/1/2025 CWM LLC4,585$53K0.0%+12,636.1%0.009% 5/1/2025 Emerald Advisers LLC898,190$10.37M0.5%+7.4%1.807% 5/1/2025 Emerald Mutual Fund Advisers Trust608,213$7.02M0.5%+10.6%1.223% 4/29/2025 Bank of New York Mellon Corp103,530$1.20M0.0%+5.1%0.208% 4/10/2025 Hennion & Walsh Asset Management Inc.111,106$1.28M0.1%+48.5%0.223% 4/8/2025 Rhumbline Advisers52,918$611K0.0%+3.4%0.106% 4/7/2025 GAMMA Investing LLC4,431$51K0.0%+567.3%0.009% 3/24/2025 Wellington Management Group LLP122,863$1.04M0.0%+4.2%0.247% 2/18/2025 Frazier Life Sciences Management L.P.4,887,867$41.40M1.7%+32.5%9.890% 2/17/2025 Woodline Partners LP1,288,401$10.91M0.1%+111.8%2.607% 2/17/2025 Vestal Point Capital LP4,770,000$40.40M2.4%+19.3%9.652% 2/17/2025 Two Sigma Investments LP13,463$114K0.0%-50.0%0.027% 2/17/2025 Two Sigma Advisers LP22,822$193K0.0%-40.4%0.046% 2/17/2025 Tang Capital Management LLC4,893,847$41.45M2.7%+13.2%9.903% 2/17/2025 Stempoint Capital LP992,803$8.41M2.1%N/A2.009% 2/17/2025 Suvretta Capital Management LLC4,913,012$41.61M1.4%+16.6%9.941% 2/17/2025 Rafferty Asset Management LLC54,466$461K0.0%+24.3%0.110% 2/17/2025 ProShare Advisors LLC11,906$101K0.0%N/A0.024% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC172,693$1.46M0.1%+27.4%0.349% 2/17/2025 Octagon Capital Advisors LP1,370,000$11.60M1.9%N/A2.772% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,386$181K0.0%-5.3%0.043% 2/17/2025 Graham Capital Management L.P.10,479$89K0.0%N/A0.021% 2/17/2025 Deutsche Bank AG35,841$304K0.0%+63.5%0.073% 2/17/2025 D. E. Shaw & Co. Inc.73,286$621K0.0%-18.5%0.148% 2/17/2025 DAFNA Capital Management LLC811,678$6.88M1.7%+12.2%1.642% “Sell Nvidia before earnings” (Ad)Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.See Eric’s full analysis and get all 7 free trade ideas here2/17/2025 Bank of America Corp DE110,050$932K0.0%+108.8%0.223% 2/17/2025 BNP Paribas Financial Markets6,252$53K0.0%-85.6%0.013% 2/17/2025 Ameriprise Financial Inc.53,382$452K0.0%N/A0.108% 2/17/2025 Algert Global LLC10,360$88K0.0%N/A0.021% 2/17/2025 Allostery Investments LP479,100$4.06M4.2%N/A0.969% 2/14/2025 Boxer Capital Management LLC1,590,000$13.47M1.1%N/A3.217% 2/14/2025 Jane Street Group LLC69,397$588K0.0%-86.6%0.140% 2/14/2025 PDT Partners LLC35,201$298K0.0%+56.8%0.071% 2/14/2025 Emerald Mutual Fund Advisers Trust549,688$4.66M0.3%-15.6%1.112% 2/14/2025 Northern Trust Corp366,170$3.10M0.0%-3.5%0.741% (Data available from 1/1/2016 forward) KALV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KALV shares? During the previous two years, 128 institutional investors and hedge funds held shares of KalVista Pharmaceuticals. The most heavily invested institutionals were Vestal Point Capital LP ($52.85M), Suvretta Capital Management LLC ($41.61M), Tang Capital Management LLC ($41.45M), Frazier Life Sciences Management L.P. ($41.40M), Vanguard Group Inc. ($26.53M), Woodline Partners LP ($18.67M), and Capital World Investors ($17.37M).Learn more on KalVista Pharmaceuticals' institutional investors. Which institutional investors have been buying KalVista Pharmaceuticals' stock? Of the 109 institutional investors that purchased KalVista Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vestal Point Capital LP ($2.47M), StemPoint Capital LP ($1.73M), Boxer Capital Management LLC ($1.59M), Frazier Life Sciences Management L.P. ($1.58M), Capital World Investors ($1.46M), Octagon Capital Advisors LP ($1.37M), and Great Point Partners LLC ($1.34M). How much institutional buying is happening at KalVista Pharmaceuticals? Institutional investors have bought a total of 16,803,528 shares in the last 24 months. This purchase volume represents approximately $163.02M in transactions. Which of KalVista Pharmaceuticals' major shareholders have been selling company stock? Of the 38 institutional investors that sold KalVista Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.14M), First Turn Management LLC ($704.54K), Jane Street Group LLC ($450.31K), JPMorgan Chase & Co. ($380.64K), Schroder Investment Management Group ($313.05K), Saturn V Capital Management LP ($192.27K), and Rosalind Advisors Inc. ($180.26K). How much institutional selling is happening at KalVista Pharmaceuticals? Institutional investors have sold a total of 4,330,106 shares in the last 24 months. This volume of shares sold represents approximately $43.99M in transactions. Related Companies RXRX Major Shareholders CPRX Major Shareholders KNSA Major Shareholders OGN Major Shareholders ALVO Major Shareholders CNTA Major Shareholders IBRX Major Shareholders TARS Major Shareholders OCUL Major Shareholders AGIO Major Shareholders This page (NASDAQ:KALV) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access